AIFM2 and cancer: Novel FSP1 inhibitors, such as improved chemical inhibitor of ferroptosis suppressor protein 1 (icFSP1), disrupt LLPS, impairing membrane localization and dimerization, thereby sensitizing cancer cells to ferroptosis [23].